Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis
- PMID: 3156575
- DOI: 10.1001/archsurg.1985.01390260016003
Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis
Abstract
The ability of Bacteroides fragilis and Escherichia coli to produce synergistic mortality when mixed into intraperitoneal (IP) fibrin clots was tested in rats. The addition of B fragilis (2 X 10(9) colony-forming units/clot) to E coli (2 X 10(8) colony-forming units/clot) in the clot significantly enhanced both early and late mortality rates when compared to either E coli or B fragilis alone. Multiple washings of B fragilis prior to mixing with E coli in the clot delayed the enhancement of lethality from 24 to 48 hours. By seven days, washed B fragilis was as synergistic with E coli as unwashed B fragilis plus E coli. Furthermore, unwashed killed B fragilis was as synergistic when mixed with E coli in the fibrin clot as unwashed living B fragilis. However, washed dead B fragilis plus E coli produced no greater mortality than E coli alone. The lethality of an IP clot containing E coli was significantly increased when B fragilis was mixed with it in the same clot, injected free IP, and or implanted into a separate IP clot. Intraperitoneal E coli-fibrin clot lethality was not increased by subcutaneous B fragilis and was only slightly enhanced by intravenous B fragilis inoculation. The strain of B fragilis used in these studies did not produce fibrinolysins at any concentration. The data support the idea that synergistic mortality between E coli and B fragilis in this model is caused by a heat-stable surface factor produced by B fragilis, which acts to increase the lethal effects of E coli.
Similar articles
-
Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.Arch Surg. 1984 Feb;119(2):139-44. doi: 10.1001/archsurg.1984.01390140005001. Arch Surg. 1984. PMID: 6365029
-
The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.Can J Microbiol. 1988 Mar;34(3):352-7. doi: 10.1139/m88-064. Can J Microbiol. 1988. PMID: 3046726
-
Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.J Med Microbiol. 1989 Aug;29(4):269-76. doi: 10.1099/00222615-29-4-269. J Med Microbiol. 1989. PMID: 2668529
-
Pathogenicity of the Bacteroides fragilis group.Ann Clin Lab Sci. 1989 Sep-Oct;19(5):360-76. Ann Clin Lab Sci. 1989. PMID: 2679351 Review.
-
Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.Rev Infect Dis. 1984 Mar-Apr;6 Suppl 1:S91-5. doi: 10.1093/clinids/6.supplement_1.s91. Rev Infect Dis. 1984. PMID: 6372042 Review.
Cited by
-
Fecal peritonitis: microbial adherence to serosal mesothelium and resistance to peritoneal lavage.World J Surg. 1990 Mar-Apr;14(2):176-83. doi: 10.1007/BF01664870. World J Surg. 1990. PMID: 2327095
-
Succinate is an inflammatory signal that induces IL-1β through HIF-1α.Nature. 2013 Apr 11;496(7444):238-42. doi: 10.1038/nature11986. Epub 2013 Mar 24. Nature. 2013. PMID: 23535595 Free PMC article.
-
Do Primocolonizing Bacteria Enable Bacteroides thetaiotaomicron Intestinal Colonization Independently of the Capacity To Consume Oxygen?mSphere. 2021 May 5;6(3):e00232-19. doi: 10.1128/mSphere.00232-19. mSphere. 2021. PMID: 33952662 Free PMC article.
-
A soluble Bacteroides by-product impairs phagocytic killing of Escherichia coli by neutrophils.Infect Immun. 1989 Mar;57(3):745-53. doi: 10.1128/iai.57.3.745-753.1989. Infect Immun. 1989. PMID: 2537256 Free PMC article.
-
Candida peritonitis: an update on the latest research and treatments.World J Surg. 2011 Dec;35(12):2650-9. doi: 10.1007/s00268-011-1305-2. World J Surg. 2011. PMID: 21976010 Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources